1. Home
  2. LARK vs CYBN Comparison

LARK vs CYBN Comparison

Compare LARK & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LARK
  • CYBN
  • Stock Information
  • Founded
  • LARK 1885
  • CYBN 2019
  • Country
  • LARK United States
  • CYBN Canada
  • Employees
  • LARK N/A
  • CYBN N/A
  • Industry
  • LARK Major Banks
  • CYBN Pharmaceuticals and Biotechnology
  • Sector
  • LARK Finance
  • CYBN Health Care
  • Exchange
  • LARK Nasdaq
  • CYBN Nasdaq
  • Market Cap
  • LARK 150.1M
  • CYBN 147.4M
  • IPO Year
  • LARK N/A
  • CYBN N/A
  • Fundamental
  • Price
  • LARK $25.92
  • CYBN $7.23
  • Analyst Decision
  • LARK
  • CYBN Strong Buy
  • Analyst Count
  • LARK 0
  • CYBN 3
  • Target Price
  • LARK N/A
  • CYBN $85.00
  • AVG Volume (30 Days)
  • LARK 7.1K
  • CYBN 988.4K
  • Earning Date
  • LARK 10-29-2025
  • CYBN 11-12-2025
  • Dividend Yield
  • LARK 3.24%
  • CYBN N/A
  • EPS Growth
  • LARK 38.73
  • CYBN N/A
  • EPS
  • LARK 2.98
  • CYBN N/A
  • Revenue
  • LARK $64,367,999.00
  • CYBN N/A
  • Revenue This Year
  • LARK N/A
  • CYBN N/A
  • Revenue Next Year
  • LARK N/A
  • CYBN N/A
  • P/E Ratio
  • LARK $8.70
  • CYBN N/A
  • Revenue Growth
  • LARK 12.95
  • CYBN N/A
  • 52 Week Low
  • LARK $19.09
  • CYBN $4.81
  • 52 Week High
  • LARK $31.04
  • CYBN $13.88
  • Technical
  • Relative Strength Index (RSI)
  • LARK 45.63
  • CYBN 62.87
  • Support Level
  • LARK $25.29
  • CYBN $6.86
  • Resistance Level
  • LARK $26.24
  • CYBN $8.00
  • Average True Range (ATR)
  • LARK 0.45
  • CYBN 0.41
  • MACD
  • LARK -0.01
  • CYBN 0.16
  • Stochastic Oscillator
  • LARK 47.73
  • CYBN 66.16

About LARK Landmark Bancorp Inc.

Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The Bank has continued to focus on increasing its originations of commercial, commercial real estate (CRE), and agricultural loans, which management believes will be more profitable and provide more growth for the Bank than traditional one-to-four-family residential real estate lending. In addition, it also invests in certain investment and mortgage-related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and southwest Kansas.

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.

Share on Social Networks: